Cargando…
Neuroimaging and analytical methods for studying the pathways from mild cognitive impairment to Alzheimer’s disease: protocol for a rapid systematic review
BACKGROUND: Alzheimer’s disease (AD) is a neurodegenerative disorder commonly associated with deficits of cognition and changes in behavior. Mild cognitive impairment (MCI) is the prodromal stage of AD that is defined by slight cognitive decline. Not all with MCI progress to AD dementia. Thus, the a...
Autores principales: | Ahmadzadeh, Maryam, Christie, Gregory J., Cosco, Theodore D., Moreno, Sylvain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118884/ https://www.ncbi.nlm.nih.gov/pubmed/32241302 http://dx.doi.org/10.1186/s13643-020-01332-7 |
Ejemplares similares
-
Neuroimaging and machine learning for studying the pathways from mild cognitive impairment to alzheimer’s disease: a systematic review
por: Ahmadzadeh, Maryam, et al.
Publicado: (2023) -
Continuing education for the prevention of mild cognitive impairment and Alzheimer’s-type dementia: a systematic review protocol
por: Matyas, Nina, et al.
Publicado: (2017) -
Predictors of the rate of cognitive decline in older adults using machine learning
por: Ahmadzadeh, Maryam, et al.
Publicado: (2023) -
Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021) -
Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease
por: Lin, Ai-Ling, et al.
Publicado: (2012)